Edition:
United States

AMAG Pharmaceuticals Inc (AMAG.O)

AMAG.O on Nasdaq

22.95USD
30 Mar 2017
Change (% chg)

$0.10 (+0.44%)
Prev Close
$22.85
Open
$22.85
Day's High
$23.25
Day's Low
$22.60
Volume
888,265
Avg. Vol
1,227,667
52-wk High
$36.83
52-wk Low
$17.92

AMAG.O

Chart for AMAG.O

About

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $784.66
Shares Outstanding(Mil.): 34.34
Dividend: --
Yield (%): --

Financials

  AMAG.O Industry Sector
P/E (TTM): -- 29.56 30.32
EPS (TTM): -0.16 -- --
ROI: -0.11 13.57 13.10
ROE: -0.27 14.48 14.24

BRIEF-Amag Pharmaceuticals, Endoceutics enter into license agreement

* Amag and Endoceutics enter into an exclusive U.S. license agreement for intrarosa (prasterone)

Feb 14 2017

BRIEF-Amag Pharmaceuticals sees Q4 2016 revenue $150 mln to $155 mln

* AMAG Pharmaceuticals provides financial and business update

Jan 09 2017

BRIEF-Amag Pharmaceuticals enters into an agreement to develop and commercialize Rekynda

* Entered into an agreement for exclusive North American rights to develop and commercialize Rekynda

Jan 09 2017

BRIEF-Amag Pharma Q3 earnings per share $0.43

* Amag pharmaceuticals reports third quarter 2016 financial results and provides corporate update

Nov 03 2016

More From Around the Web

Competitors

  Price Chg
Takeda Pharmaceutical Co Ltd (4502.T) ¥5,344 +205.00
Sanofi SA (SASY.PA) €84.24 -0.27
Fresenius Medical Care AG & Co. KGaA (FMEG.DE) €78.80 +0.16
Galenica AG (GALN.S) CHF1,060.00 +11.00

Earnings vs. Estimates